1800 202 8726
IHC Markers Explained

p53 on Your Biopsy Report — What the Result Actually Means

A p53 result on a biopsy describes how a protein is behaving inside the tumour. It is not a test for an inherited gene fault, and it does not tell you whether your family members are at risk without further investigation.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • A tumour finding, not a genetic test — IHC staining shows the protein pattern inside biopsy cells — not the DNA you were born with.
  • Aberrant means abnormal pattern — It describes how p53 protein looks under staining — not how serious the cancer is.
  • Inherited risk is a separate question — If family history raises concern, your oncologist can refer you to a clinical genetics service for blood testing.
  • Your oncologist reads the full picture — p53 is one marker among several. No single marker decides a diagnosis or treatment plan on its own.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

p53 is a protein that normally stops damaged cells from dividing. On a biopsy, an aberrant p53 result shows this protein is behaving abnormally in the tumour cells. This is a finding about the tumour's biology — not a test for a gene you inherited from your parents or could pass to your children.

What do the terms on a p53 biopsy result mean?

p53
A protein that detects damaged DNA and stops it spreading. When p53 stops working, damaged cells can keep dividing.
TP53 gene
The gene that instructs cells to make p53 protein. A fault inside a tumour cell is a somatic mutation. An inherited fault present in every body cell since birth — a germline mutation — is a separate, rarer thing.
IHC (immunohistochemistry)
A staining test on biopsy tissue. It uses antibodies to show whether p53 protein is present and how it is distributed across the tumour cells.
Aberrant expression
An abnormal staining pattern — either far too much p53 protein, or none at all. Both count as aberrant.
Wild-type expression
The staining pattern seen when p53 is functioning normally. It means no obvious p53 abnormality was detected in the cells tested.
Null / complete absence
Almost no p53 staining detected. This usually means a mutation is preventing the protein from being made.

What a p53 IHC result does — and does not — tell you

  • It shows how p53 protein behaves in your tumour cells — not in the rest of your body.
  • It does not confirm an inherited gene fault. That requires a separate blood test reviewed by a clinical geneticist.
  • The word 'aberrant' describes the protein staining pattern — not how aggressive the cancer is.
  • p53 is read alongside cancer type, stage, and other markers — never on its own.
  • If inherited risk concerns you, ask your oncologist whether a genetics referral is appropriate.
  • Do not draw conclusions from this result alone. Discuss it with your oncologist before acting on it.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Did you know?

TP53 is the most frequently altered tumour suppressor gene identified across human cancers, according to the IARC TP53 Database. In most cases the mutation arises inside the tumour during a person's lifetime and is not inherited from — or passed on to — anyone else.

Source: IARC TP53 Database, International Agency for Research on Cancer

Questions patients ask about p53 results

Does an aberrant p53 result mean I have an inherited gene fault?

Not on its own. IHC describes the protein pattern in tumour cells — it is not a genetic test of your inherited DNA. An inherited TP53 fault is rare and is diagnosed through a blood test combined with a family history review by a clinical geneticist. If your oncologist suspects inherited risk based on your history or age at diagnosis, they will arrange that referral separately.

What is the difference between a strong positive and a null p53 result?

Strong positive means a high concentration of p53 protein across many tumour cells — often from a mutation that makes a faulty, stable form of the protein accumulate. Null means almost no staining, usually because a mutation has stopped the protein from being made. Both are aberrant patterns. The same pattern can mean different things in different cancer types, so it is always interpreted in context.

Should my family members be tested because of this result?

This result alone does not mean your family should be tested. IHC describes your tumour cells — not your inherited DNA. A blood test for a germline TP53 mutation is only recommended after a clinical geneticist has reviewed your personal and family history. Talk to your oncologist first, who can advise whether a genetics referral is appropriate and coordinate any testing.

Will p53 status affect which treatment I receive?

For some cancer types, the p53 IHC pattern influences how the pathologist classifies the tumour, which can in turn affect the treatment pathway. Treatment decisions are based on the full picture — cancer type, stage, other markers, and your fitness. What your specific result means for your management is a conversation to have directly with your oncologist.

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What does p53 positive mean on a biopsy report?

p53 positive usually refers to an aberrant IHC staining pattern — either abnormally high protein concentration or its complete absence. Both are considered abnormal. Different laboratories use the term differently, so ask your oncologist exactly which pattern was found and what it means for your specific cancer type. It is one of several findings the pathologist and oncologist read together.

Does an abnormal p53 result mean my cancer is more aggressive?

Not necessarily. The relationship between p53 status and cancer behaviour depends heavily on the cancer type. For some cancers it is one factor in classification; for others the picture is different. Your oncologist interprets p53 alongside the tumour grade, stage, and other markers. If you are concerned about what it means for your outlook, raise that directly with your treating team.

What is the difference between p53 IHC and a TP53 gene test?

p53 IHC is a protein test on biopsy tissue — it shows whether p53 is present and how it is behaving in the tumour cells. A TP53 gene test examines the DNA directly: in tumour tissue to find somatic mutations, or in blood to look for an inherited germline mutation. An abnormal IHC result does not tell you whether the fault is inherited. A genetic blood test is needed for that question.

Can a p53 result change between biopsies?

Yes. Tumours evolve, so a result from an early biopsy may differ from a later one. This does not mean the first test was wrong — it may reflect genuine change in the tumour, or the two biopsies may have sampled different areas. Your oncologist accounts for the full biopsy history when interpreting your results.

Is p53 tested on every cancer biopsy?

No. p53 IHC is ordered when it is clinically relevant to the specific cancer type being investigated. It is commonly tested in gynaecological cancers, certain breast cancers, and other tumour types where p53 status aids classification. Your oncologist or pathologist can explain why it was ordered for your biopsy and what the result contributed to understanding your cancer.

What should I ask my oncologist about the p53 result?

Ask three things: what the specific staining pattern was, what it means for your cancer type, and whether it changes anything about your management. If there is a history of multiple cancers in your family at younger ages, also ask whether a genetics referral is appropriate. Write down the answers — these conversations are hard to recall accurately under stress.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation